Global Metabolomics Market Size To Exceed USD 15.34 Billion By 2035 | CAGR of 13.8%
Category: HealthcareGlobal Metabolomics Market Size To Exceed USD 15.34 Billion By 2035
According to a research report published by Spherical Insights & Consulting, The Global Metabolomics Market Size is expected to grow from USD 3.70 Billion in 2024 to USD 15.34 Billion by 2035, at a CAGR of 13.8% during the forecast period 2025-2035.
Get more details on this report -
Browse 210 Market Data Tables And 45 Figures Spread Through 190 Pages and In-Depth TOC On the “Global Metabolomics Market Size, Share, and COVID-19 Impact Analysis, By Product & Services (Metabolomics Instruments, Separation Tools, and Detection Tools), By Application (Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, and Others), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035.” Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/metabolomics-market
The global industry devoted to the study and analysis of metabolites small compounds generated during cellular metabolism using cutting-edge technologies such as nuclear magnetic resonance and mass spectrometry, combined with bioinformatics, is included in the metabolomics market. It facilitates applications in toxicology, personalized medicine, drug development, and biomarker discovery. The market enables thorough metabolic profiling to comprehend disease mechanisms and therapeutic responses, driven by rising R&D investments and the need for precision healthcare. The metabolomics market is fueled by a number of important elements that work together to support its strong expansion and growing applications in the clinical and scientific fields. The growing demand for personalized medicine due to the prevalence of chronic diseases, R&D investments in biotechnology and pharmaceuticals, improvements in analytical technologies like mass spectrometry, and significant government-private funding for toxicology applications and biomarker discovery are driving the metabolomics market. However, the scalability of the metabolomics market is restricted by high instrument prices, a lack of data standards, a paucity of qualified professionals, and intricate regulatory frameworks.
The instruments segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.
Based on the product & services, the metabolomics market is divided into metabolomics instruments, separation tools, and detection tools. Among these, the instruments segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. These instruments give researchers the ability to measure metabolites in a precise, repeatable, and comprehensive manner. High-precision detection frequently makes use of sophisticated technologies, including chromatography, NMR spectroscopy, and mass spectrometry.
The biomarker discovery segment accounted for the largest share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.
Based on the application, the metabolomics market is divided into biomarker discovery, drug discovery, toxicology testing, nutrigenomics, functional genomics, personalized medicine, and others. Among these, the biomarker discovery segment accounted for the largest share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. Biomarker discovery are used by biotech and pharmaceutical companies to increase drug efficacy testing and clinical trial success rates. Metabolomics is also used by academic researchers to find biomarkers for chronic and metabolic diseases.
North America is expected to hold the majority share of the global metabolomics market during the forecast period.
Get more details on this report -
North America is expected to hold the majority share of the global metabolomics market during the forecast period. North America is propelled by significant R&D expenditures, cutting-edge analytical tools like mass spectrometry, and NIH-funded projects like the Multi-Omics Consortium. The region's emphasis on personalized medicine and biomarker development, combined with the increased frequency of chronic diseases, guarantees a sustained market.
Asia Pacific is anticipated to grow at the fastest pace in the global metabolomics market during the forecast period. The Asia Pacific region is credited with growing research projects, growing demand for personalized treatment, and increased investments in healthcare infrastructure. Positive governmental regulations and increased knowledge of the uses of metabolomics also support the region's vibrant market growth.
Major vendors in the global metabolomics market are Evotec SE Metabolon, Inc. Waters Corporation Creative Proteomics Danaher Corporation Shimadzu Corporation Owlstone Medical Ltd. Agilent Technologies, Inc. NIHS Metabolomics Core Bio-Rad Laboratories, Inc. Biocrates Life Sciences AG Thermo Fisher Scientific Inc. Metabolomic Discoveries GmbH Human Metabolome Technologies, Inc. and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In September 2024, the Irish deep-tech business Metabolomics Diagnostics, which specializes in collaborations in the creation of new biomarkers, was collected by Trinity Biotech plc, a commercial-stage biotechnology company that focuses on diabetes management solutions, including biosensors, and human diagnostics. remedies for complicated illnesses.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the metabolomics market based on the below-mentioned segments:
Global Metabolomics Market, By Product & Services
- Metabolomics Instruments
- Separation Tools
- Detection Tools
Global Metabolomics Market, By Application
- Biomarker Discovery
- Drug Discovery
- Toxicology Testing
- Nutrigenomics
- Functional Genomics
- Personalized Medicine
- Others
Global Metabolomics Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?